| Trial ID: | L2676 |
| Source ID: | NCT02586129
|
| Associated Drug: |
Yh14755
|
| Title: |
Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Dyslipidemia|Type II Diabetes
|
| Interventions: |
DRUG: YH14755|DRUG: Metformin|DRUG: Rosuvastatin
|
| Outcome Measures: |
Primary: Change in LDL Cholesterol, Change from baseline at 16 weeks|Change in HbA1c, Change from baseline at 16 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Yuhan Corporation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
249
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2015-11-04
|
| Completion Date: |
2017-07-07
|
| Results First Posted: |
|
| Last Update Posted: |
2018-10-03
|
| Locations: |
Seoul National Universitiy Bundang Hospital, Seongnam-Si, Gyeonggi-Do, 463-707, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02586129
|
